| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.372 | 48.178 | 49.139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 22.372 | 48.178 | 49.192 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 16.504 | 39.342 | 41.655 | 1.478 | 308 | 303 | 116 | 122 | 121 | 1.356 |
| Gross Profit/Loss - EUR | 5.868 | 8.836 | 7.536 | -1.478 | -308 | -303 | -116 | -122 | -121 | -1.356 |
| Net Profit/Loss - EUR | 5.197 | 7.390 | 6.061 | -1.478 | -308 | -303 | -116 | -122 | -121 | -1.356 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Annona Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 161 | 440 | 216 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.425 | 15.885 | 21.486 | 19.419 | 12.413 | 11.549 | 11.177 | 11.090 | 10.935 | 5.684 |
| Inventories | 2.445 | 7.612 | 2.385 | 2.341 | 2.296 | 2.252 | 2.202 | 2.209 | 2.203 | 6 |
| Receivables | 616 | -1.860 | 445 | 456 | 447 | 438 | 429 | 430 | 429 | 98 |
| Cash | 4.364 | 10.132 | 18.656 | 16.622 | 9.671 | 8.858 | 8.546 | 8.451 | 8.304 | 5.580 |
| Shareholders Funds | 5.242 | 12.579 | 17.113 | 15.321 | 8.062 | 7.606 | 7.322 | 7.223 | 7.080 | 5.684 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.364 | 3.767 | 4.589 | 4.098 | 4.352 | 3.943 | 3.855 | 3.867 | 3.856 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4662 - 4662" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Annona Med Srl